BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 8890164)

  • 1. Association of inhibitory tyrosine protein kinase p50csk with protein tyrosine phosphatase PEP in T cells and other hemopoietic cells.
    Cloutier JF; Veillette A
    EMBO J; 1996 Sep; 15(18):4909-18. PubMed ID: 8890164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SH2 domain-mediated interaction of inhibitory protein tyrosine kinase Csk with protein tyrosine phosphatase-HSCF.
    Wang B; Lemay S; Tsai S; Veillette A
    Mol Cell Biol; 2001 Feb; 21(4):1077-88. PubMed ID: 11158295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory tyrosine protein kinase p50csk is associated with protein-tyrosine phosphatase PTP-PEST in hemopoietic and non-hemopoietic cells.
    Davidson D; Cloutier JF; Gregorieff A; Veillette A
    J Biol Chem; 1997 Sep; 272(37):23455-62. PubMed ID: 9287362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cooperative inhibition of T-cell antigen receptor signaling by a complex between a kinase and a phosphatase.
    Cloutier JF; Veillette A
    J Exp Med; 1999 Jan; 189(1):111-21. PubMed ID: 9874568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Domain interactions in protein tyrosine kinase Csk.
    Sondhi D; Cole PA
    Biochemistry; 1999 Aug; 38(34):11147-55. PubMed ID: 10460171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequence requirements for association of protein-tyrosine phosphatase PEP with the Src homology 3 domain of inhibitory tyrosine protein kinase p50(csk).
    Gregorieff A; Cloutier JF; Veillette A
    J Biol Chem; 1998 May; 273(21):13217-22. PubMed ID: 9582365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular cloning of lsk, a carboxyl-terminal src kinase (csk) related gene, expressed in leukocytes.
    McVicar DW; Lal BK; Lloyd A; Kawamura M; Chen YQ; Zhang X; Staples JE; Ortaldo JR; O'Shea JJ
    Oncogene; 1994 Jul; 9(7):2037-44. PubMed ID: 7516063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Src and Csk families of tyrosine protein kinases in hemopoietic cells.
    Chow LM; Veillette A
    Semin Immunol; 1995 Aug; 7(4):207-26. PubMed ID: 8520026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recruitment of C-terminal Src kinase by the leukocyte inhibitory receptor CD85j.
    Sayós J; Martínez-Barriocanal A; Kitzig F; Bellón T; López-Botet M
    Biochem Biophys Res Commun; 2004 Nov; 324(2):640-7. PubMed ID: 15474475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Requirement of the SH3 and SH2 domains for the inhibitory function of tyrosine protein kinase p50csk in T lymphocytes.
    Cloutier JF; Chow LM; Veillette A
    Mol Cell Biol; 1995 Nov; 15(11):5937-44. PubMed ID: 7565746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel mechanism of regulation of the non-receptor protein tyrosine kinase Csk: insights from NMR mapping studies and site-directed mutagenesis.
    Shekhtman A; Ghose R; Wang D; Cole PA; Cowburn D
    J Mol Biol; 2001 Nov; 314(1):129-38. PubMed ID: 11724538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-terminal Src kinase (CSK) and CSK-homologous kinase (CHK)--endogenous negative regulators of Src-family protein kinases.
    Chong YP; Mulhern TD; Cheng HC
    Growth Factors; 2005 Sep; 23(3):233-44. PubMed ID: 16243715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proline-rich sequences mediate the interaction of the Arg protein tyrosine kinase with Crk.
    Wang B; Mysliwiec T; Feller SM; Knudsen B; Hanafusa H; Kruh GD
    Oncogene; 1996 Oct; 13(7):1379-85. PubMed ID: 8875975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel, specific interaction involving the Csk SH3 domain and its natural ligand.
    Ghose R; Shekhtman A; Goger MJ; Ji H; Cowburn D
    Nat Struct Biol; 2001 Nov; 8(11):998-1004. PubMed ID: 11685249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The SH3 and SH2 domains are capable of directing specificity in protein interactions between the non-receptor tyrosine kinases cSrc and cYes.
    Summy JM; Guappone AC; Sudol M; Flynn DC
    Oncogene; 2000 Jan; 19(1):155-60. PubMed ID: 10644991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification of bovine thymus cytosolic C-terminal Src kinase (CSK) and demonstration of differential efficiencies of phosphorylation and inactivation of p56lyn and pp60c-src by CSK.
    Cheng HC; Bjorge JD; Aebersold R; Fujita DJ; Wang JH
    Biochemistry; 1996 Sep; 35(36):11874-87. PubMed ID: 8794770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrophobic interaction between the SH2 domain and the kinase domain is required for the activation of Csk.
    Mikkola ET; Gahmberg CG
    J Mol Biol; 2010 Jun; 399(4):618-27. PubMed ID: 20434462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular interactions of the Src homology 2 domain protein Shb with phosphotyrosine residues, tyrosine kinase receptors and Src homology 3 domain proteins.
    Karlsson T; Songyang Z; Landgren E; Lavergne C; Di Fiore PP; Anafi M; Pawson T; Cantley LC; Claesson-Welsh L; Welsh M
    Oncogene; 1995 Apr; 10(8):1475-83. PubMed ID: 7537362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis for domain-domain communication in a protein tyrosine kinase, the C-terminal Src kinase.
    Lin X; Wang Y; Ahmadibeni Y; Parang K; Sun G
    J Mol Biol; 2006 Apr; 357(4):1263-73. PubMed ID: 16483606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement.
    Moarefi I; LaFevre-Bernt M; Sicheri F; Huse M; Lee CH; Kuriyan J; Miller WT
    Nature; 1997 Feb; 385(6617):650-3. PubMed ID: 9024665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.